For more than four decades, Fenwick & West has helped some of the world’s most recognized companies become, and remain, market leaders. From emerging enterprises to large public corporations, our clients are leaders in the technology, life sciences and cleantech sectors and are fundamentally changing the world through rapid innovation.
Fenwick & West was founded in 1972 in the heart of Silicon Valley—before “Silicon Valley” existed—by four visionary lawyers who left a top-tier New York law firm to pursue their shared belief that technology would revolutionize the business world and to pioneer the legal work for those technological innovations. In order to be most effective, they decided they needed to move to a location close to primary research and technology development. These four attorneys opened their first office in downtown Palo Alto, and Fenwick became one of the first technology law firms in the world.
From our founding in 1972, Fenwick has been committed to promoting diversity and inclusion both within our firm and throughout the legal profession. For almost four decades, the firm has actively promoted an open and inclusive work environment and committed significant resources towards improving our diversity efforts at every level.
At Fenwick, we are proud of our commitment to the community and to our culture of making a difference in the lives of individuals and organizations in the communities where we live and work. We recognize that providing legal services is not only an essential part of our professional responsibility, but also an excellent opportunity for our attorneys to gain valuable practical experience, learn new areas of the law and contribute to the community.
Year after year, Fenwick & West is honored for excellence in the legal profession. Many of our attorneys are recognized as leaders in their respective fields, and our Corporate, Tax, Litigation and Intellectual Property Practice Groups consistently receive top national and international rankings, including:
We take sustainability very seriously at Fenwick. Like many of our clients, we are adopting policies that reduce consumption and waste, and improve efficiency. By using technologies developed by a number of our cleantech clients, we are at the forefront of implementing sustainable policies and practices that minimize environmental impact. In fact, Fenwick has earned recognition in several areas as one of the top US law firms for implementing sustainable business practices.
At Fenwick, we have a passion for excellence and innovation that mirrors our client base. Our firm is making revolutionary changes to the practice of law through substantial investments in proprietary technology tools and processes—allowing us to deliver best-in-class legal services more effectively.
Mountain View Office
Silicon Valley Center
801 California Street
Mountain View, CA 94041
San Francisco Office
555 California Street
San Francisco, CA 94104
1191 Second Avenue
Seattle, WA 98101
Dr. Shuster is a partner in Fenwick & West's Intellectual Property Practice and is co-chair of the firm's Life Sciences Group.
Dr. Shuster has legal and technical experience representing companies in biotechnology and high technology areas that include protein and nucleic acid chemistry, clean tech, high resolution protein structures, proteomics, genomics, combinatorial peptide libraries, vaccine development for viral and autoimmune disorders, transdermal drug delivery systems, liposomal drug formulations as well as microfluidics devices.
Dr. Shuster received his undergraduate education at Brandeis University, graduating with a B.A. in Biophysics. He recieved his J.D. from the University of San Francisco School of Law and his Ph.D. from Columbia University's Department of Physiology and Molecular Biophysics. While at Columbia he worked with Professor Eric Kandel as part of a team focused on discovery of mechanisms by which short term memories are stored, work for which Professor Kandel was awarded the Nobel Prize in Medicine in 2000. Dr. Shuster pursued his interests in ion channel biophysics and protein structure, first as a Markey post-doctoral fellow at UCSF's Department of Biochemistry & Biophysics, and then as a research biochemist studying neuronal mechanisms of pain transduction in UCSF's Department of Medicine.
Currently, Dr. Shuster is a co-instructor of "A Life Scientist's Guide to Intellectual Property" at UCSF, and regularly lectures about intellectual property law subjects. He is past chair of the Intellectual Property section of the Barrister's Club of San Francisco. Dr. Shuster was named one of Top 25 Biotech Lawyers in California in 2011 and one of the Top 25 Intellectual Property Portfolio Managers in 2009 and 2012 by the Daily Journal. He was also recognized as a "Life Sciences Star" for his outstanding patent work in Euromoney's LMG Life Sciences 2012.
Dr. Shuster has published numerous scientific papers in peer-reviewed journals as well as articles on biotechnology patent law. Representative technologies for which he's written and prosecuted patent applications include genomics, proteomics, bioinformatics, vaccines, microfluidic devices, drug delivery methods and microarrays.